CMOs eye Russia for growth

Russia is striving to produce domestically 50% of the drugs sold in the country, and, to do so, it's encouraging global manufacturers to buy, build or rent facilities there.

InVentiv joins a nonprofit effort to make trials more efficient

CRO inVentiv Health has agreed to share its expertise with the nonprofit Alliance for Clinical Research Excellence and Safety (ACRES), working to develop global standards for clinical trials.

Risk-sharing CRO Ergomed banks $18.9M and awaits a U.K. IPO

U.K. researcher Ergomed is set to debut on the London stock exchange, raising £11 million ($18.9 million) to wrap up an acquisition and expand its global footprint.

U.K. CRO emerges from $100M in deals with plans for more M&A

With the help of U.K. investor Equistone, newly minted CRO Concept Life Sciences has snapped up three contractors and set out to do business as a conglomerate, scouting for clients looking to outsource scientific work.

Nicox's $120M Aciex deal gives CRO Ora a bigger partner

Ophthalmic CRO Ora is inheriting a relationship with drugmaker Nicox after the French outfit agreed to buy Aciex Therapeutics, a Boston-based biotech at work on eye treatments.

AMRI eyes a big year after completing another buyout

Contract developer AMRI has closed its $110 million acquisition of drug manufacturer Oso Biopharmaceuticals, its second deal this year and one the company believes will help pad its annual revenue.

Quintiles extends its commercial capabilities with Encore buyout

Quintiles has wrapped up its acquisition of healthcare analytics provider Encore, part of the CRO's push to grow its post-market services.

BioOutsource plots a U.S. expansion with eyes on biosimilars

Scottish contractor BioOutsource is planning a deeper dive into the U.S. market for development services, setting sights on a new lab in Massachusetts to serve its American clientele.

Catalent eyes a Japanese expansion after 40 years in the country

Contract developer Catalent is planning to open a new facility in Japan as it marks 40 years doing business in the country, looking to expand its scale in R&D and manufacturing.

Parexel eyes the Middle East with its latest CRO buyout

Parexel International is looking to broaden its presence in the Middle East and North Africa, snapping up Turkish CRO Atlas Medical Services.

Recipharm and CTC unite for early-stage trials

Contract developer Recipharm and CTC Clinical Trial Consultants are joining forces to offer combined Phase I services, pooling their capabilities in manufacturing and trial conduction.

Evotec pockets a payment in its Boehringer partnership

German contractor Evotec has notched another milestone in its years-long arrangement with Boehringer Ingelheim, netting €1 million ($1.4 million) after moving a respiratory compound into preclinical study.

ClinicalRM teams up with an Ohio network for clinical trials

CRO ClinicalRM has signed a deal with the Ohio Clinical Trials Collaborative to join forces in a co-marketing arrangement, looking to expand its role in the state's drug and device development scene.

Bristol-Myers enlists Duke's CRO to help it share trial data

Bristol-Myers Squibb has tapped Duke University's in-house CRO to pitch in on clinical trial transparency, asking the organization's researchers to independently review requests for shared data.

Parexel expects to hit the $2B mark in fiscal 2015

Parexel figures it can rake in more than $2 billion in revenue in the next fiscal year, banking on a solid book-to-bill ratio and increasing global demand to deliver an all-time high.

Covance is creating an OkCupid for molecules

As last week's BIO conference well illustrated, biotech companies go to great lengths to flaunt their assets in front of potential partners from Big Pharma. Global CRO Covance is developing a system it believes can make that process more efficient: an online platform that allows drug developers to securely list their up-for-license molecules for would-be collaborators.

Teva settles with Catalent, Perrigo in inhaler patent suit

Catalent and Perrigo will be able to sell generic versions of Teva's ProAir HFA inhaler starting in late 2016, resolving a patent dispute between the two parties.

Parexel rolls out new eClinical tech to speed up study start-up

Parexel International has reformatted its clinical trial management software, streamlining its services with an update the company believes can help its clients start studies faster.

Simbec buys its way into late-stage R&D with Orion deal

Welsh CRO Simbec Research is expanding beyond its focus on early-phase studies, buying up Orion Clinical Services in a move the company says will make it a full-service organization.

Japanese CRO taps BBK for a U.S. joint venture

Japan's CROèe, a patient-recruitment-focused contractor, has deepened its ties with partner BBK, launching a joint venture in the U.S. to provide a gateway into the country's growing market for drug development.